Mary Acila Goretti
ID: UNCST-2025-R020322
|
COMPARATIVE PERFORMANCE OF THE SMALL EAST AFRICAN ZEBU AND ITS CROSSES WITH TYROLEAN GREY CATTLE IN ASWA RANCH AND LUSENKE STOCK FARM OF UGANDA
REFNo: A653ES
1. To determine morphological traits and structural indices of the Small East African Zebu and its crosses with Tyrolean Grey cattle under on station conditions in Aswa Ranch and Lusenke Stock farm.
2. To determine milk production and growth performance of the Small East African Zebu and its crosses with Tyrolean Grey cattle under on station conditions in Aswa Ranch and Lusenke Stock farm.
3. To determine reproductive performance of the Small East African Zebu and its crosses with Tyrolean Grey cattle under on station conditions in Aswa Ranch and Lusenke Stock farm.
|
Uganda |
2025-11-04 17:55:57 |
2028-11-04 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Alex Bashaija Sande
ID: UNCST-2024-R002629
|
Influence of social norms on child marriage in Busolwe Town Council, Butaleja District
REFNo: SS3758ES
1) To find out the influence of social norms on child marriage in Busolwe Town Council, Butaleja District.
2) To identify the social norms that contribute to child marriage in Busolwe Town Council.
3) To establish the reference groups that reinforce social norms related to child marriage in Busolwe Town Council.
4) To examine the social sanctions and their effect on sustaining the practice of child marriage in Busolwe Town Council.
|
Uganda |
2025-11-04 17:23:42 |
2028-11-04 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Zerubabeeli Naturinda
ID: UNCST-2025-R019082
|
Farmers’ knowledge and incentives for using tree species on Robusta coffee farms in Uganda
REFNo: A619ES
To contribute to enhancing climate-resilient and sustainable Robusta coffee production systems by generating evidence on farmers' knowledge of tree species use and the key factors influencing their integration on Robusta coffee farms within the Lake Victoria Crescent and Western Savannah Grasslands agroecological zones of Uganda.
Specifically, the study will; (i) assess farmers’ knowledge and knowledge processes about tree species integration on Robusta coffee farms, (ii) determine the drivers for farmers’ decisions to integrate tree species on Robusta coffee farms, and (iii) determine the contribution of integrating tree species on Robusta coffee farms in adapting to climate variability.
|
Uganda |
2025-11-04 16:42:56 |
2028-11-04 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Barbara Kunihira Evelyn
ID: UNCST-2025-R019727
|
Study on Usability and Acceptability Evaluation of Compact Prefilled Auto disable Devices (CPAD) for Injectable Contraceptives Delivery in Uganda.
REFNo: HS6685ES
This study aims to assess the user and programmatic acceptability of the Easyject™ and BFS CPAD devices in Uganda, with a focus on their potential to improve access to injectable contraceptives. The specific objectives include:
1. To understand if these devices are acceptable and appropriate for delivery of contraceptives (both self-delivery and provider use).
2. To understand user perspectives regarding device usability, safety, and overall satisfaction.
3. Understand retraining requirements (time, materials, methods).
Device-Specific Objectives
1. Easyject™: Assess usability improvements in the updated design, particularly around needle shield removal and injection force.
2. BFS CPAD: Collect first-time user feedback on the usability and acceptability of the design.
|
Uganda |
2025-11-04 16:40:38 |
2028-11-04 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Edgar Twine
ID: UNCST-2025-R018607
|
Consumer valuation of a novel healthy food product in Uganda: Evidence from experimental auctions.
REFNo: A664ES
To examine the effect of information and sensory testing on consumer valuation of ORYLUX 6 rice variety in Uganda
To compare consumer valuation of a novel and healthy food product across three countries and regions, namely, Uganda in East Africa, Cameroon in Central Africa and Cote d’Ivoire in West Africa.
|
Uganda |
2025-11-04 16:39:25 |
2028-11-04 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
simpson kamugisha
ID: UNCST-2024-R003681
|
Understanding the post-accident experience of Boda boda drivers: Case study Mbarara City, Uganda
REFNo: SS4365ES
To explore can the support needed by boda boda drivers who have experienced accidents in Uganda,To examine the post-accident experiences of boda boda drivers in Uganda,
|
Uganda |
2025-11-04 14:15:13 |
2028-11-04 |
Social Science and Humanities |
|
Degree Award |
|
Barbara Nayebare Baturaine
ID: UNCST-2025-R021900
|
AN ASSESSMENT TO UNDERSTAND THE DIFFERENT TARGET AUDIENCE NEEDS (INCLUDING THEIR KNOWLEDGE, ATTITUDES, BELIEFS, AND PRACTICES), AND DEVELOP APPROPRIATE BEHAVIOR CHANGE COMMUNICATION AND MARKETING STRATEGIES
REFNo: SS4464ES
The objective of the survey is to carry out a detailed Knowledge, attitude and Practice survey and design of an evidence-based National FMNR Social Marketing and Behavioral Change Communications Strategy (2023-2028). This document is to be used for communication, marketing and implementation of programs to promote socially beneficial behavior change towards the adoption and scale up of FMNR. This will be informed by primary data collection to inform the development of the strategy.
|
Uganda |
2025-11-04 13:44:41 |
2028-11-04 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
VICTORIA NAKAGIMU MWAZI
ID: UNCST-2025-R020484
|
FOOD ENVIRONMENT, DIETARY PATTERNS AND NUTRITIONAL STATUS OF SECONDARY SCHOOL TEACHERS IN KAMPALA CITY
REFNo: HS6358ES
To assess the food environment of secondary school teachers in Kampala City, Uganda.
(ii) To analyse the food consumption patterns of secondary school teachers in Kampala City, Uganda.
(iii) To assess the nutritional status and associated factors of secondary school teachers in Kampala city.
(iv) To explore the perceptions of stakeholders on the food environment, diet and the nutritional status of secondary school teachers in Kampala City.
|
Uganda |
2025-11-04 13:42:47 |
2028-11-04 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Opportuna Kweka Leo
ID: UNCST-2025-R021025
|
STRENGTHENING KNOWLEDGE, EVIDENCE USE AND LEADERSHIP IN THE GLOBAL SOUTH ON FORCED DISPLACEMENT: WITH A FOCUS ON EAST AFRICA
REFNo: SS4309ES
Conduct research on forced displacement, namely refugees, internally displaced persons and development/conservation/disaster and climate changed induced displacement).
(ii) Build capacity on forced displaced issues through seminars, training of masters, PhD and postdoctoral students doing research on forced displacement.
(iii) Work with policy makers to discuss the state of the knowledge, constraining factors and possible angles for inclusion of those marginalized.
(iv) Work with NGOs to conduct outreach activities either expanding and upscaling existing outreach activities (originating from refugees or external actors) or start new empowerment programmes on social and legal inclusion.
(v) Develop a master’s programme on forced displacement, which will be offered in the Department of Geography at the University of Dar es Salaam
|
Tanzania |
2025-11-04 13:40:10 |
2028-11-04 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Peter Alinda
ID: UNCST-2025-R020482
|
PHYSICAL PLANNING AND URBANIZATION IN UGANDA: A CASE OF FORT PORTAL CITY, CENTRAL DIVISION
REFNo: SS4377ES
General Objective (Purpose) of the Study
The study is to evaluate the effect of physical planning on urbanization in Fort Portal City, Uganda.
Specific Objectives of the Study
i.To assess the effect of Urban Design on urbanisation in Fort Portal City.
ii.To examine the influence of Enforcement Mechanism on Urbanisation in Fort Portal City.
iii.To evaluate the contribution of Monitoring & Evaluation on urbanisation in Fort Portal
|
Uganda |
2025-11-04 13:37:44 |
2028-11-04 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Stephen Okoboi
ID: UNCST-2019-R001356
|
Amplifying Community Voices and Lived Experience of the Perceived Impact of Climate Change on Health among Community Health Workers in Namayingo District, Uganda
REFNo: SS4546ES
1.Document CHW experiences of the intersection between climate change and health among individuals, families, and communities.
2.Assess CHW experiences of how climate change affects their role and the health system more broadly.
3.Describe CHW perspectives on community strength and resilience in the face of the climate crisis, including local solutions.
4.Explore CHW recommendations for developing a climate-informed health workforce and climate-resilient health systems and communities.
|
Uganda |
2025-11-04 13:34:31 |
2028-11-04 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Prosper Behumbiize
ID: UNCST-2025-R019986
|
Uganda’s Digital Mental Health Leap Harnessing DHIS2 for Data-Driven Insights
REFNo: HS6407ES
The project seeks to address Uganda's mental health data quality, access and utilisation gap by leveraging the DHIS2 platform to digitise the depression and anxiety facility data pipeline, from data generation to analysis and insight generation.
Primary objectives
The specific objectives are;
- Create a harmonised, digitised dataset to enable access of individual granular longitudinal mental health data.
- Design and deploy an open-access digital tool and dataset repository to ensure transparency, scalability, and ease of access to analytical outputs.
- Engage stakeholders in capacity-strengthening activities.
Secondary objectives
- Conduct secondary data analysis using open-source Artificial Intelligence (AI) and Machine Learning (ML) models to derive actionable insights from standardised datasets.
- Generate policy-relevant outputs, including dashboards, open-source publications, and policy briefs, to inform decision-making at various levels.
|
Uganda |
2025-11-04 13:33:24 |
2028-11-04 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
HOPE KANSIIME
ID: UNCST-2024-R004499
|
Designing an optimised framework for effective usage and efficient access of Electronic resources in the consortium of Ugandan university libraries
REFNo: SIR561ES
To establish the acceptability and usability of the developed framework designed to enhance the access and usage of e –resources within the consortium of Uganda university libraries,To design and develop an optimised framework aimed at improving the accessibility and utilization of e-resources within the consortium of Uganda university libraries,To determine the necessary prerequisites for creating an optimized framework that will improve the accessibility and utilization of e-resources in the consortium of Uganda university libraries?,To conduct a cross-sectional study to evaluate how E-resources are utilised, examine access patterns and identify barriers and challenges to their usage within the consortium of Uganda university libraries,To optimise Electronic resource utilisation in Ugandan university consortium by developing an efficient access and usage framework,
|
Uganda |
2025-11-04 13:31:17 |
2028-11-04 |
Engineering and Technology |
Non-Clinical Trial |
Degree Award |
|
Edwin Nuwagira
ID: UNCST-2021-R013488
|
Improving Diagnostic Strategies for Post-Tuberculosis Lung Disease in Ugandan Primary Health Care Settings (IMPULSE-TB)
REFNo: HS6402ES
To test the feasibility and acceptability of the diagnostic algorithm in facilitating timely post-TB lung diseasediagnosis at primary healthcare facilities,To use qualitative methods to identify barriers and facilitators of diagnosis to post-TB lung disease,To develop, test and validate a clinical algorithm for diagnosing post-TB lung disease based on clinical and sociodemographic characteristics,
|
Uganda |
2025-11-04 13:29:51 |
2028-11-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
Francis Pebalo Pebolo
ID: UNCST-2022-R010630
|
Incidence, risk factors and clinical outcomes of neonatal sepsis among HIV-exposed infants of mothers on dolutegravir-based antiretroviral therapy in Uganda
REFNo: HS6486ES
Comparing 28-day clinical outcomes of mothers with HIV on DTG-based ART compared with their HIV negative counterparts.,To compare 28-day clinical outcomes among HIV-exposed neonates of mothers on DTG-based ART and HIV-unexposed neonates.,To compare sepsis incidence risk factors among HIV-exposed neonates of mothers on DTG-based ART and HIV-unexposed neonates,To conduct a scoping review to describe the epidemiology of neonatal sepsis of neonates born to mothers with HIV comparing outcomes on DTG- and non-DTG-containing regimens,
|
Uganda |
2025-11-04 13:00:07 |
2028-11-04 |
Medical and Health Sciences |
|
Degree Award |
|
ERIC WOBUDEYA
ID: UNCST-2019-R001047
|
Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV
REFNo: HS6555ES
Primary Objectives
Cohort 1 and Cohort 2
• To determine the weight-band dosing of RPT taken as part of the 1HP regimen by evaluating:
⎯ PK RPT exposures among children with and without HIV
⎯ Safety and tolerability of the 1HP regimen among children with HIV while receiving twice-daily DTG and children without HIV through 28 days of dosing
Cohort 2
• To evaluate the effect of RPT taken as part of the 1HP regimen on the PK of DTG
Secondary Objectives
Cohort 1 and Cohort 2
• To evaluate the effect of covariates including age, weight, sex, ethnicity, nutritional status, and HIV-1 status on the PK of RPT taken as part of the 1HP regimen
• To evaluate the safety of the 1HP regimen through 24 weeks of follow-up
• To evaluate the palatability and acceptability of the 1HP regimen
• To evaluate adherence to the 1HP regimen
Cohort 2
• To evaluate the safety and tolerability of twice-daily DTG through 42 days among children with HIV who are receiving 1HP
• To evaluate virologic control (less than 200 copies/mL) at Day 42 among children taking a DTG-based ARV treatment regimen co-administered with 1HP
|
Uganda |
2025-11-04 12:59:17 |
2028-11-04 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
ConfiSign HIV/Syphilis Combo Self-Test: Evaluation of Clinical Performance and Usability in the hands of untrained users.
REFNo: HS6687ES
Untrained users will either take part in the label comprehension study and results interpretation study (part A) or in the observed untrained user study (part B). Untrained users enrolled for the label comprehension and results interpretation study (part A), shall not participate in the observed user study (part B) and vice versa.,The primary and overall objective of this study is to evaluate the performance and the usability of the ConfiSign HIV/Syphilis Combo Self-Test in the hands of untrained users from a low prevalence HIV region (< 5%) who have no, or limited experience in self-testing. ,
|
Uganda |
2025-10-29 16:22:26 |
2028-10-29 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Specioza Namakula
ID: UNCST-2025-R021710
|
EMPOWERING MOBILITY: Assessing the Impact of Buffalo Bicycles on Refugee and host Communities in Uganda. A case study of Bidi Bidi, Rhino Camp and Palabek refugee settlements
REFNo: SS4566ES
I. To generate data that will support Learning and evidence-based decision making.
II. To provide systematic and objective information for bicycle usage in refugee communities.
III. Generating information that is required to inform advocacy and further bicycle provision for vulnerable communities.
IV. To determine the effectiveness, efficiency and relevance of bicycles in improving accessibility to essential services like education, health and economic empowerment.
|
Uganda |
2025-10-29 16:20:00 |
2028-10-29 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Victor Musiime
ID: UNCST-2021-R013794
|
Enhancing Novel Research for Inflammation and Cognitive Health among Adolescents and Young Adults Living with Perinatally Acquired HIV and Adversity (ENRICH+)
REFNo: HS6607ES
Specific Aim 1: Investigate differences in ID and NCI in demographically matched, virally suppressed PHIV and HHIV, as well as HUU AYA (15-25 years old) in Uganda while controlling for chronic adversities. Hypothesis 1 (H1): Both ID and NCI will be respectively higher in PHIV vs. HHIV vs. HUU AYA. H2: Within the two HIV groups, those with delayed ART initiation and lower nadir CD4 cell count at ART initiation will have higher ID and worse NCI.
Specific Aim 2: Investigate the relationship between ID and NCI in AYA within all three groups (PHIV, HHIV and HUU) controlling for chronic adversities. H3: There will be a positive association between ID and NCI in each group. H4: In a subset of PHIV and HUU AYA with prior repeated measures of ID, worsening trajectories of ID in PHIV across 6 years will be associated with worse NCI.
Specific Aim 3: Investigate the effects of co-occurring adversities (i.e., profiles) on the relationships between HIV, ID, and NCI. H5: Adversity profiles will be more severe respectively in PHIV vs. HHIV vs. HUU. H6: The strength of association between medical and psychosocial (e.g., stigma, mental health) adversities, ID and NCI will be strongest in PHIV vs. HHIV vs. HUU, respectively.
|
Uganda |
2025-10-29 16:07:10 |
2028-10-29 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Henry Mugerwa
ID: UNCST-2019-R000420
|
A5402 An Open-Label, Randomized Controlled Trial of Pramipexole versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD with Mild Neurocognitive Disorder (MND) in Persons with HIV
REFNo: HS6604ES
1.2 Primary Objectives
1.2.1 To compare pramipexole to escitalopram in the treatment of MDD (and comorbid MDD with MND) based on the Beck Depression Inventory-II (BDI-II/BDI-2) total score [Beck 1996] from baseline to week 24.
1.2.2 To evaluate the safety of pramipexole and escitalopram in PWH having MDD (and comorbid MDD with MND) from baseline to week 24.
1.3 Secondary Objectives
1.3.1 To compare pramipexole to escitalopram in the treatment of MDD using MDD caseness, neurocognitive outcomes, and functional status from baseline to week 24.
1.3.2 To compare the depression, neurocognitive, and functional status outcomes in PWH with MDD alone and with comorbid MDD with MND treated with pramipexole versus escitalopram from baseline to week 24.
1.3.3 To compare the impact of pramipexole and escitalopram on all outcomes above by female versus male sex (assigned at birth) from baseline to week 24.
1.3.4 To determine the impact of pramipexole compared to escitalopram on the measure of HIV-1 RNA viral load in the peripheral blood.
1.4 Exploratory Objectives
1.4.1 To characterize associations between escitalopram trough concentrations and treatment efficacy (BDI-II/BDI-2 total score) as well as participant adverse events (adverse event frequency, severity, and discontinuation rates).
1.4.2 To characterize associations between escitalopram trough concentrations and genetic polymorphisms that affect metabolizing enzymes of escitalopram (known metabolizing enzymes include CYP2C19, CYP2D6, and CYP3A4).
1.4.3 To explore associations between cerebrospinal fluid (CSF) concentrations of escitalopram and BDI-II/BDI-2 total score.
1.4.4 To evaluate adverse events potentially related to drug interactions between antiretroviral therapy (ART) and escitalopram and pramipexole, respectively.
1.5 Substudy Objective
1.5.1 CSF Substudy
To compare the impact of pramipexole and escitalopram on biomarker outcomes in a CSF substudy of participants with MDD alone.
|
Uganda |
2025-10-29 16:04:25 |
2028-10-29 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|